Posterior chamber phakic IOL corrects myopia but has high complication rate
Click Here to Manage Email Alerts
Posterior chamber phakic IOL implantation offered predictable and stable refractive outcomes in correcting moderate to high myopia; however, high rates of serious complications occurred, according to a study.
The retrospective study included 53 eyes of 29 patients with moderate to high myopia. All eyes received the PRL posterior chamber phakic IOL (IOL Tech/Carl Zeiss Meditec). Patients’ mean age was 34.6 years.
PC IOL insertion was performed through a 2.75-mm clear corneal tunnel incision on the steepest meridian to reduce postoperative residual astigmatism.
Postoperative outcomes were assessed at 1 day, 1 week, 1 and 3 months, 1 year and annually thereafter. Mean follow-up was 86 months.
Mean uncorrected distance visual acuity improved from 1.37 to 0.14 at final follow-up; mean corrected distance visual acuity improved from 0.10 to –0.01. Both gains were statistically significant (P < .01).
Correction was within 0.5 D of the target in 42 eyes (79.2%) and within 1 D in 50 eyes (94.3%) at 3 months.
Mean endothelial cell loss was 6.9% at 10 years. Slight PC IOL decentration occurred in five eyes (9.4%). One eye (1.8%) had severe decentration and underwent lens extraction at 5 months.
Glaucoma occurred in four eyes (7.5%), clinically significant cortical lens opacification in four eyes and retinal detachment in two eyes (3.8%), according to the authors.
Disclosure: The study authors report no relevant financial disclosures.